Filing Details
- Accession Number:
- 0001209191-11-032550
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-02 16:46:59
- Reporting Period:
- 2011-06-01
- Filing Date:
- 2011-06-02
- Accepted Time:
- 2011-06-02 16:46:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236387 | N James Wilson | C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-06-01 | 10,000 | $4.90 | 2,014,511 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2011-06-01 | 5,000 | $4.90 | 921,774 | No | 4 | S | Indirect | By Family Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Family Partnership |
Footnotes
- The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.